(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate (1:1)(CAS: 709031-45-8)

The compound is subject to global regulatory guidelines such as REACH in Europe, which requires registration, evaluation, authorization, and restriction of chemicals. In the U.S., FDA and EPA guidelines apply for pharmaceutical and environmental safety. It is important to follow local and national regulations for proper handling and disposal.

Synthetic alternatives include various amides and methanesulfonates of other cyclic amines. Analogous compounds like (1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate can serve as alternatives. Other reagents such as amino acids or cyclic peptides may also be used depending on the specific synthesis requirements.

The market trend for this compound reflects increasing research interest in cyclic amines due to their potential in medicinal chemistry and bioactivity. Research is focusing on developing new therapeutic agents, with trends toward more sustainable and environmentally friendly synthesis methods. Pricing remains stable with moderate demand in academic and industrial sectors.

Waste containing this compound should be collected in appropriate containers and stored separately. Incineration is a common disposal method, but professional waste disposal services are recommended for safe handling. Environmental protection measures include adhering to local regulations, proper labeling, and minimizing environmental exposure during disposal.